Glaucoma

Five new aqueous humor biomarkers of POAG progression are identified

Investigators find the recognition could improve surveillance of the disease.

Orbis International kicks off Virtual Flying Eye Hospital program in Ethiopia

The 10-week Flying Eye Hospital program will offer courses focusing on advanced glaucoma and simulation lectures for residents.

New noninvasive technology shows positive safety and efficacy for the treatment of open angle glaucoma

Two year data shows a promising future for the OCD guided, noninvasive technology for glaucoma treatment.

Patricia Bath, MD, inducted into the National Inventors Hall of Fame

May 05, 2022

Bath was recognized as the first Black woman physician to receive a medical patent, as well as the first woman to lead a post-graduate training program in ophthalmology. She joins four other inventors as the most recent inductees into the Hall.

Blog: TAGS trial and real life applications

May 02, 2022

Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.

Chronic IOP elevation impacts cerebrovascular reactivity in murine visual cortex/basal forebrain

May 01, 2022

Investigators from the New York University Grossman School of Medicine presented data at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver that concluded mapping of the relative cerebrovascular reactivity in the murine brain showed widespread brain changes resulting from the chronic IOP elevation, and demonstrates vascular involvement in glaucoma both within and beyond the primary visual pathways.

Advances in cyclophotocoagulation: Good, better, best

April 28, 2022

Ophthalmologists have seen a progression in cyclophotocoagulation (CPC), with each generation becoming more doctor and patient friendly. Shan C. Lin, MD, a glaucoma specialist at the Glaucoma Center of San Francisco in California, described the advances in the technology.